Advancing Prognostic Tools for Individualized Treatment in Metastatic Cancer
The following is a summary of “Future Directions in the Evaluation and Management of newly...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 2160 results for 'metastatic cancer'
Metastatic Cancer Survival No Better at Practices With Higher NQF 0210 Rates
WEDNESDAY, May 22, 2024 (HealthDay News) — For patients with metastatic or advanced cancer,...
Read More
Home-Return of Critically Ill Metastatic Cancer Patients Following Unplanned ICU Stay
The following is a summary of “Critically ill metastatic cancer patients returning home...
Read More
Aggressive End-of-Life Care Often Used in Seniors With Metastatic Cancer
FRIDAY, Feb. 24, 2023 (HealthDay News) — Aggressive end-of-life (EOL) care is commonly used...
Read More
Impact of Electronic Symptom Monitoring in Metastatic Cancer Patients
For a study, researchers sought to determine whether electronic symptom monitoring during cancer...
Read More
Unnecessary RT Given Near End of Life in Metastatic Cancer
TUESDAY, Jan. 18, 2022 (HealthDay News) — Among patients with bone and brain metastases who...
Read More
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial.
Liver compresses are frequently used in integrative medicine as supportive therapy during cancer...
Read More
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study.
Stereotactic ablative body radiotherapy (SABR) is increasingly being used to treat oligometastatic...
Read More
Tumor size-dependent abscopal effect of polydopamine-coated all-in-one nanoparticles for immunochemo-photothermal therapy of early- and late-stage metastatic cancer.
Metastatic cancer is a persistent clinical enigma, which requires combination of several treatment...
Read MoreAdvertisement
Exosomal miR-193a and let-7g accelerate cancer progression on primary colorectal cancer and paired peritoneal metastatic cancer.
A metastasis of colorectal cancer is difficult to diagnose, and has a poor prognosis. Therefore,...
Read More
The Brain Microenvironment Induces DNMT1 Suppression and Indolence of Metastatic Cancer Cells.
Brain metastasis is an ineffective process, and many cancer cells enter into an indolent state...
Read More
Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.
Pancreatic cancer is a leading cause of cancer-related deaths in the U.S. Ninety percent of...
Read More
Hypothyroidism correlates with favourable survival prognosis in patients with brain metastatic cancer.
Several preclinical and epidemiologic studies have indicated tumour-promoting effects of thyroid...
Read More
Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers.
Immune checkpoint inhibitors (ICIs) are approved in multiple indications for cancer care. Most of...
Read More
Stereotactic Radiation Feasible for Oligometastatic Cancer
SABR associated with low toxicity and good survival while maintaining quality of life
Read More
Palliative Care for Metastatic Cancer
Nearly half of all patients with metastatic cancer have incurable disease, but these individuals...
Read MoreA Post Hoc Analysis of Older Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Plus Bevacizumab: The Randomized Obelics Study.
Phase II trials and subgroup analyses of clinical studies suggest that bevacizumab plus an oxaliplatin-based chemotherapy doublet is effective and tolerable in fit older patients with metastatic colorectal cancer (mCRC).To...
Read More
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
WEDNESDAY, Feb. 19, 2025 (HealthDay News) — For patients with metastatic...
Read More
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved...
Read MoreThe Safety and Efficacy of Targeted Alpha Therapy, Ac-225 Prostate-Specific Membrane Antigen, in Patients With Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis.
Metastatic castration resistance prostate cancer (mCRPC) is a challenging disease with a significant burden of mortality and morbidity. Most of the patients attain resistance to the available treatments, necessitating further...
Read More